InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (1 ops.)
Insider track record
OtherDisclosed buys
3
Disclosed sells
1
T+90 hit rate
100%
T+90 mean return
+3.1%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Matrix Capital Management Company, LP. Insider active across 2 companies, notably Aura Biosciences, Inc.. In total, 5 reports have been published. Breakdown: 3 buys · 1 sell. Total volume traded: €134.6m. History available since 5 December 2022. The latest transaction was disclosed on 15 December 2025 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations5 total
7,500,000 shares@ US$1.337.9% of flowCommon Stock, par value $0.001 per shareSEC:0000902664-25-005288:0
1,560,000 shares@ US$9.0048.0% of flowCommon Stock, par value $0.00001 per share (Common Stock)SEC:0000902664-23-005429:0
Canonical exit: 7 Feb 2024 (T+90)
4,760,000 shares@ US$22.66100.0% of flowCommon Stock, par value $0.001 per shareSEC:0000902664-23-003642:0
Canonical exit: 18 Sept 2023 (T+90)
1,250,000 shares@ US$12.0052.0% of flowCommon Stock, par value $0.00001 per share ("Common Stock")SEC:0000902664-22-005061:0
Canonical exit: 5 Mar 2023 (T+90)
2,327,870 sharesCommon Stock, par value $0.00001 per share ("Common Stock")SEC:0000902664-21-004738:0
5 of 5 declarations
About Matrix Capital Management Company, LP
Matrix Capital Management Company, LP is a declarant linked to Aura Biosciences, Inc. and Zentalis Pharmaceuticals, Inc. It has filed 5 filings in total, and across the 5 sampled recent filings, the transactions are acquisitions, with EUR 126105602 of buys, EUR 0 of sells, between 2021-11-04 and 2023-11-09.
